Cargando…
Erratum to lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073786/ https://www.ncbi.nlm.nih.gov/pubmed/35530969 http://dx.doi.org/10.21037/atm-2022-6 |
Ejemplares similares
-
Lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma
por: Du, Yu, et al.
Publicado: (2021) -
The Lipoxin A4 Receptor Agonist BML-111 Alleviates Inflammatory Injury and Oxidative Stress in Spinal Cord Injury
por: Liu, Jian, et al.
Publicado: (2020) -
The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin against Ultraviolet B Radiation
por: Martinez, Renata M., et al.
Publicado: (2020) -
Effect of the Lipoxin Receptor Agonist BML-111 on Cigarette Smoke Extract-Induced Macrophage Polarization and Inflammation in RAW264.7 Cells
por: Cao, En, et al.
Publicado: (2023) -
Lipoxin A4 receptor agonist BML-111 induces autophagy in alveolar macrophages and protects from acute lung injury by activating MAPK signaling
por: Liu, Huaizheng, et al.
Publicado: (2018)